Putney's pet skin care drug gets FDA OK
Portland-based Putney Inc. has received FDA approval for a generic drug to treat skin infections in dogs.
The company's Cefpodoxime Proxetil is the only generic with FDA-approved equivalence to the brand-name Simplicef, according to a company press release.
Based on the company's analysis of drugs approved by the FDA's Center for Veterinary Medicine, it found that only 7% of approved drugs for dogs and cats have a veterinary generic equivalent.
That contrasts with the market for prescription drugs for humans, where nearly 80% of FDA-approved drugs have generic equivalents, according to a study by the IMS Institute for Healthcare Informatics.
The company estimates the market for Cefpodoxime Proxetil at around $25 million.
Read more
Putney sold for $200M to UK veterinary company; founder to leave
Most Recent
Most Recent
Comments